Company Tagline
New generation of efficient, affordable transfection reagents based on combinatorial chemical synthesis and cell screens
Industry Category
Business Keywords
Company Description
ScreenFect GmbH is at the forefront of biotechnology research, dedicated to developing and providing innovative solutions for gene and drug delivery. Leveraging advanced lipid synthesis technology, ScreenFect GmbH creates diverse lipid libraries and employs high-throughput screening with live cells to identify highly efficient and non-toxic gene delivery systems.
ScreenFect GmbH is committed to advancing biotechnology through cutting-edge research and development. Located at Hermann-von-Helmholtz Pl. 1, KIT High-Tech Inkubator, b. 717, Eggenstein-Leopoldshafen, 76344, DE, the company is strategically positioned to foster collaboration and innovation. ScreenFect GmbH strives to deliver next-generation transfection reagents that are both efficient and affordable.
ScreenFect GmbH’s focus on combinatorial chemical synthesis and cell screens ensures that its products meet the highest standards of quality and performance. As a leader in biotechnology research, ScreenFect GmbH is poised for continued growth and success. We invite the management team to enhance this description and showcase your products in a customized and exclusive company presentation on our platform.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
BioIndustry Association (BIA)
Biotechnology-ResearchThe award-winning trade association for the innovative life sciences and biotech companies in the UK
Alternative Company Names
This company is also known as